TICKERNOMICS Sign up
Last Update: 2024-12-27 15:29:54
BIOMERICA INC ( BMRA ) https://www.biomerica.com
0.33USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-72.46%
BMRA
SPY
32.66%
-91.73%
BMRA
SPY
108.59%
-87.96%
BMRA
SPY
302.52%
-59.88%
BMRA
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
4.58
2.46
0.38
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.74
0.83
0.86
-74.10
0.00
-0.46
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-75.71
15.99
-74.54
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
-0.9056
-64.84
-70.15
-1.42
Other Earnings and Cash Flow Stats:
BIOMERICA INC ( BMRA ) Net Income TTM ($MM) is -5.26
BIOMERICA INC ( BMRA ) Operating Income TTM ($MM) is -5.47
BIOMERICA INC ( BMRA ) Owners' Earnings Annual ($MM) is 0.00
BIOMERICA INC ( BMRA ) Current Price to Owners' Earnings ratio is 0.00
BIOMERICA INC ( BMRA ) EBITDA TTM ($MM) is -5.39
BIOMERICA INC ( BMRA ) EBITDA Margin is -74.54%
Capital Allocation:
BIOMERICA INC ( BMRA ) has paid 0.00 dividends per share and bought back 0.0 million shares in the past 12 months
BIOMERICA INC ( BMRA ) has reduced its debt by 0.23 million USD in the last 12 months
Capital Structure:
BIOMERICA INC ( BMRA ) Interest-bearing Debt ($MM) as of last quarter is 0
BIOMERICA INC ( BMRA ) Annual Working Capital Investments ($MM) are 0
BIOMERICA INC ( BMRA ) Book Value ($MM) as of last quarter is 5
BIOMERICA INC ( BMRA ) Debt/Capital as of last quarter is 13%
Other Balance Sheet Stats:
BIOMERICA INC ( BMRA ) has 2 million in cash on hand as of last quarter
BIOMERICA INC ( BMRA ) has 2 million of liabilities due within 12 months, and long term debt 0 as of last quarter
BIOMERICA INC ( BMRA ) has 16 common shares outstanding as of last quarter
BIOMERICA INC ( BMRA ) has 0 million USD of preferred stock value
Academic Scores:
BIOMERICA INC ( BMRA ) Altman Z-Score is -8.44 as of last quarter
BIOMERICA INC ( BMRA ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
BIOMERICA INC ( BMRA ) largest shareholder is GROUP ONE TRADING LLC owning 41 shares at 0.00 ($MM) value
Zackary S Irani(an insider) Bought 500 shares of BIOMERICA INC ( BMRA ) for the amount of $805.00 on 2023-05-24
7.22% of BIOMERICA INC ( BMRA ) is held by insiders, and 13.01% is held by institutions
BIOMERICA INC ( BMRA ) went public on 2005-01-03
Other BIOMERICA INC ( BMRA ) financial metrics:
FCF:-5.47
Unlevered Free Cash Flow:0.00
EPS:-0.31
Operating Margin:-75.71
Gross Profit Margin:15.99
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-98.47
Beta:-1.42
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About BIOMERICA INC ( BMRA ) :
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; Helicobacter pylori test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.